Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Eprodisate is a novel compound specifically developed to disrupt the interactions between amyloidogenic proteins and glycosaminoglycans, effectively impeding the polymerization of amyloid fibrils and their deposition in tissues. This compound shows potential for delaying the advancement of AA amyloidosis-related renal disease and could apply to various forms of amyloidosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
50 mg | Inquiry | Inquiry | |
100 mg | Inquiry | Inquiry |
Description | Eprodisate is a novel compound specifically developed to disrupt the interactions between amyloidogenic proteins and glycosaminoglycans, effectively impeding the polymerization of amyloid fibrils and their deposition in tissues. This compound shows potential for delaying the advancement of AA amyloidosis-related renal disease and could apply to various forms of amyloidosis. |
Molecular Weight | 204.21 |
Formula | C3H8O6S2 |
CAS No. | 21668-77-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Eprodisate 21668-77-9 inhibitor inhibit